Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sustainable and Efficient Platform of New Therapeutic Development for Early Breast Cancer (S-FACT)

NCT06535893 is registered in ClinicalTrials.gov with Nagoya City University as lead sponsor.

NCT NCT06535893
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06535893 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sustainable and Efficient Platform of New Therapeutic Development for Early Breast Cancer (S-FACT)
Lead sponsor
Nagoya City University
Phase
Phase 2
Overall status
Recruiting
Start date
July 30, 2024
Completion date
June 30, 2040
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer